"Health Canada approval of the Fisher Wallace Stimulator® medical device is a significant milestone for Fisher Wallace Laboratories and for insomnia and chronic pain patients across Canada," said Charles Fisher, president of Fisher Wallace Laboratories. Food and Drug Administration (FDA) since 1991. Widely used in the United States, the Fisher Wallace Stimulator® has been cleared for the treatment of insomnia, anxiety, depression and chronic pain by the U.S. NEW YORK, /CNW/ - Fisher Wallace Laboratories announced today that it has received Health Canada approval of the Fisher Wallace Stimulator® medical device for the treatment of insomnia and chronic pain. Prices subject to change.Insomnia and chronic pain patients can now find relief from innovative brain stimulation device
If you have any questions about the products you see here or previous purchases, please contact StackCommerce support here. This post does not constitute editorial endorsement. VentureBeat Deals is a partnership between VentureBeat and StackCommerce. They can choose to receive the current original version, or wait and get the upgraded version 2 set to be released next March.
Fisher wallace stimulator free#
Investors who contribute more than $1,500 will also receive a free Fisher Wallace stimulator device. Named one of the 5 Health-Tech Startups to Watch in 2021 by Entrepreneur Magazine, Fisher Wallace is now seeking outside investment to help ramp up production of the device worldwide. In another study, patients dealing with alcohol and drug recovery also showed real improvement with the use of the device, with patients in a 90-day rehab program showing 50 percent higher retention rates than those not using the device.įDA-cleared and backed by winning study showings, the Fisher Wallace device is now being prescribed by over 14,000 providers nationwide, with over 70,000 devices now in use. In a study published in the Journal of Nervous and Mental Disease, the Fisher Wallace device was shown to be significantly effective in the treatment of depression. Patients who use the device for 20 minutes once or twice each day reported experiencing fewer anxiety and depression symptoms within the first week of use.Īnd that isn’t just anecdotal information.
Since its creation, the device has been the subject of intensive scientific testing and practical use, resulting in overwhelmingly high effectiveness rates with virtually no side effects. Worn around the head like a headband, the stimulator comfortably induces the brain to begin producing serotonin, the natural body chemical that stabilizes mood while increasing feelings of well-being and happiness. The treatment also combats the natural production of cortisol, the body’s main naturally-occurring steroid hormone produced in times of stress or anxiety. Unlike medications that can have debilitating side effects on its users, the Fisher Wallace device is a non-invasive, wearable treatment that only takes about 20 minutes each day. An electrotherapy device created to treat symptoms of depression, anxiety and insomnia, the company is now seeking investor capital to help establish a new standard of care treating millions of patients suffering those disorders.
Meanwhile, the cost of antidepressants like Prozac and Sarafem can also set patients back each month. That’s a lot of money to spend on therapies that often produce limited to even negligible results.ĭiscouraging facts like those are what led Fisher Wallace, a leading non-surgical electronics company, to come up with its first product, the Fisher Wallace Stimulator. Of course, the average cost of a therapy session generally ranges from $65 per hour to as high as $250 or more.